Cyclic AMP-dependent phosphorylation of thromboxane A(2) receptor-associated Galpha(13)

Area of Science:

• Biochemistry
• Molecular Biology
• Platelet Physiology

Background:

• Cyclic adenosine monophosphate (cAMP) is a known inhibitor of platelet activation.
• The thromboxane A(2) (TXA2) signaling pathway exhibits particular sensitivity to cAMP-mediated inhibition.

Purpose of the Study:

• To investigate whether cAMP-dependent kinase mediates the phosphorylation of the TXA2 receptor-G-protein complex.
• To elucidate the molecular mechanism underlying cAMP's preferential inhibition of TXA2 signaling.

Main Methods:

• Utilized [gamma-(32)P]ATP labeling to detect cAMP-induced phosphorylation of solubilized membrane proteins.
• Employed ligand affinity chromatography to purify TXA2 receptor-G-protein complexes.
• Performed immunoprecipitation with Galpha(13) antibodies to quantify phosphorylation levels.
• Studied phosphorylation in intact, (32)P-labeled platelets treated with prostacyclin and an adenylate cyclase inhibitor.

Main Results:

• cAMP induced protein kinase A-dependent phosphorylation of G-alpha subunits (38-45 kDa).
• Phosphoproteins in the 38-45 kDa range co-purified with TXA2 receptors.
• 8-Br-cAMP significantly increased phosphorylation of TXA2 receptor-associated Galpha(13) (87%) and purified Galpha(13) (53%).
• Prostacyclin treatment of platelets increased Galpha(13) phosphorylation (90%), which was blocked by an adenylate cyclase inhibitor.

Conclusions:

• Protein kinase A mediates the phosphorylation of Galpha(13) in platelets, both in vitro and in vivo.
• This phosphorylation provides a molecular basis for the preferential inhibition of TXA2-mediated signaling by cAMP.